Skip to main content
. Author manuscript; available in PMC: 2023 Mar 16.
Published in final edited form as: Nat Rev Rheumatol. 2021 Jun 3;17(7):426–439. doi: 10.1038/s41584-021-00621-2

Figure 1. Regulation of HIF-1α in hypoxic NP cells.

Figure 1.

A) Schematic of the intervertebral disc tissue compartments and vasculature. The absence of vasculature in disc compartments makes the NP tissue physiologically hypoxic resulting in robust HIF-1α expression. B) Oxygen dependent mechanisms of HIF-α regulation. In the presence of sufficient O2, PHD2 hydroxylates proline residues in the ODD of HIF-1α targeting it for VHL-mediated polyubiquitination and 26S proteasomal degradation. PHD2 function can be blocked by two mechanisms: 1) Lactate accumulation generates metabolic intermediates, including pyruvate and succinate, which compete with the PHD2 substrate, 2-OG, and inhibit PHD activity. 2) Class I and II HDACs directly inhibit HIF-PHD2 axis. Unlike PHD2, PHD3 serves as a cofactor for transcriptional activation of C-TAD dependent target genes. In NP cells, HIF-1 function is refractory to FIH mediated inhibition. C). Oxygen-independent mechanisms of HIF-α regulation. HIF-1α can be targeted for 26S degradation by HSP70 possibly through displacement of HSP90. In NP cells, HIF-1α is a circadian clock-regulated gene. BMAL1 and RORα synergize to upregulate N-TAD and C-TAD dependent target genes, without evidence of direct binding to HIF-α. HDAC6 is shown to recruit HSP90 as a cofactor to upregulate HIF target gene expression, whereas CCN2 was reported to block HIF-1α cofactor binding and diminish its activity.